Victor Quiroz

Mr. Victor Quiroz

Johns Hopkins University
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SNSarah Neshat
Sarah Neshat
Victor QuirozVictor Quiroz
Victor Quiroz
YWYuanjia Wang
Yuanjia Wang
Sebastian TamayoSebastian Tamayo
Sebastian Tamayo
JDJoshua Doloff
Joshua Doloff
The liver is an organ with impressive regenerative potential and has been shown to heal sizable portions after their removal. However, certain diseases can overstimulate its potential to self-heal and cause excessive cellular matrix and collagen buildup. Decompensation of liver fibrosis leads to cirrhosis, a buildup of fibrotic ECM that impedes the liver’s ability to efficiently exchange fluid. This review summarizes the complex immunological activities in different liver diseases, and how failure to maintain liver homeostasis leads to progressive fibrotic tissue development. We also discuss a variety of pathologies that lead to liver cirrhosis, such as alcoholic liver disease and chronic hepatitis B virus (HBV). Mesenchymal stem cells are widely studied for their potential in tissue replacement and engineering. Herein, we discuss the potential of MSCs to regulate immune response and alter the disease state. Substantial efforts have been performed in preclinical animal testing, showing promising results following inhibition of host immunity. Finally, we outline the current state of clinical trials with mesenchymal stem cells and other cellular and non-cellular therapies as they relate to the detection and treatment of liver cirrhosis.

16 June 2023 in Science Advances
Verified
Journal Article
Open access
JDJoshua Doloff
Joshua Doloff
MMMinglin Ma
Minglin Ma
ASAtieh Sadraei
Atieh Sadraei
HTHok Hei Tam
Hok Hei Tam
SFShady Farah
Shady Farah
DADaniel G. Anderson
Daniel G. Anderson
Biomedical devices comprise a major component of modern medicine, however immune-mediated fibrosis and rejection can limit their function over time. Here, we describe a humanized mouse model that recapitulates fibrosis following biomaterial implantation. Cellular and cytokine responses to multiple biomaterials were evaluated across different implant sites. Human innate immune macrophages were verified as essential to biomaterial rejection in this model and were capable of cross-talk with mouse fibroblasts for collagen matrix deposition. Cytokine and cytokine receptor array analysis confirmed core signaling in the fibrotic cascade. Foreign body giant cell formation, often unobserved in mice, was also prominent. Last, high-resolution microscopy coupled with multiplexed antibody capture digital profiling analysis supplied spatial resolution of rejection responses. This model enables the study of human immune cell–mediated fibrosis and interactions with implanted biomaterials and devices.

20 January 2024 in Advanced Biology
Verified
Journal Article
Closed access
Victor QuirozVictor Quiroz
Victor Quiroz
YWYuanjia Wang
Yuanjia Wang
ARAmanda I. Rakoski
Amanda I. Rakoski
DKDevi Kasinathan
Devi Kasinathan
SNSarah Neshat
Sarah Neshat
JDJoshua Doloff
Joshua Doloff

29 May 2026 in Nature Immunology
Verified
Journal Article
Closed access
VSVance Soares
Vance Soares
Victor QuirozVictor Quiroz
Victor Quiroz
MTMartin Trapecar
Martin Trapecar
DKDeok-Ho Kim
Deok-Ho Kim
JDJoshua Doloff
Joshua Doloff

28 April 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JSJessica L. Stelzel
Jessica L. Stelzel
SBStuart J. Bauer
Stuart J. Bauer
BNBobby Y.X. Ni
Bobby Y.X. Ni
ZYZhi-Cheng Yao
Zhi-Cheng Yao
Victor QuirozVictor Quiroz
Victor Quiroz
JDJoshua Doloff
Joshua Doloff
The ability to induce tissue regeneration on demand using biomaterials remains a major goal in biomedical research, yet significant challenges persist. Among the most advanced biomaterial models, the nanofiber-hydrogel composite has demonstrated a striking ability to induce soft adipose tissue remodeling at the injection site without incorporating exogenous biological cues. 1,2 However, the underlying mechanisms that drive such a tissue response remain unclear. Here, we show that biomaterial-induced tissue remodeling is driven by sustained and controlled inflammation mediated by macrophages in strong communication with fibroblasts. Notably, both pro-inflammatory and anti-inflammatory signals remained elevated during this process in the long-term, challenging the prevailing notion that inflammation opposes remodeling. Using macrophage depletion in mice, we demonstrate that macrophages are essential for this process. Single-cell RNA sequencing further revealed robust fibroblast-to-macrophage signaling, contrasting with the conventional macrophage-to-fibroblast paradigm, and identified unique Spp1 ⁺ macrophages and Ctla2a ⁺ fibroblasts within the remodeling niche. These findings provide a comprehensive view of the immune landscape in biomaterial-induced tissue remodeling, highlighting key cellular interactions, prolonged kinetics, and unexpected signaling pathways. By defining key targets and fundamental principles, this work has broad implications for advancing biomaterial-induced tissue regeneration.

20 July 2026 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
JHJamie L. Hernandez
Jamie L. Hernandez
NPNeeti R. Prasad
Neeti R. Prasad
JDJonathan Daniel
Jonathan Daniel
Victor QuirozVictor Quiroz
Victor Quiroz
SCSabrina Chen
Sabrina Chen
JDJoshua Doloff
Joshua Doloff